<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02325999</url>
  </required_header>
  <id_info>
    <org_study_id>ESDLD2013</org_study_id>
    <secondary_id>BeijingFHMH2013</secondary_id>
    <nct_id>NCT02325999</nct_id>
  </id_info>
  <brief_title>Endoscopic Submucosal Dissection Combine With Laparoscopic Regional Lymph Node Dissection for Early Gastric Cancer</brief_title>
  <official_title>Endoscopic Submucosal Dissection Combine With Laparoscopic Regional Lymph Node Dissection:a New Therapy for Early Gastric Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Friendship Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Endoscopic Submucosal Dissection combine
      with Laparoscopic Regional Lymph node Dissection for early gastric cancer can improve
      Disease-free survival ？
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with early stage of gastric cancer(T1a/T1bN0M0,NCCN2014.V1) will depart into two
      group randomized double-blind, then experimental group accept Endoscopic Submucosal
      Dissection combine with Laparoscopic Regional Lymph node Dissection ,and control group accept
      Endoscopic Submucosal Dissection only.The follow-up time is from operation to recrudescence.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>DFS</measure>
    <time_frame>Five years</time_frame>
    <description>Follow-up Disease-free Survival</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Early Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>ESD and LRLD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental group accept Endoscopic Submucosal Dissection Combine With Laparoscopic Regional Lymph Node Dissection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Endoscopic Submucosal Dissection (ESD)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The group accept Endoscopic Submucosal Dissection only.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ESD AND LRLD</intervention_name>
    <description>A new therapy for gastric cancer : Endoscopic Submucosal Dissection combine with Laparoscopic Regional Lymph node Dissection.</description>
    <arm_group_label>ESD and LRLD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  cT1a：ulcer（+）and lesion diameter&gt;3cm and differentiated type. Any ulcer and lesion
             diameter d&gt;2cm and poorly differentiated type.

          -  cT1b: Submucosal injection (+)

        Exclusion Criteria:

          -  metastasis

          -  recrudescence
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shu-tian ZHANG</last_name>
    <role>Study Chair</role>
    <affiliation>Beijing Friendship Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hua MENG</last_name>
    <phone>+8613488882358</phone>
    <email>Meng.doctor@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Qiu-yue ZHANG</last_name>
    <phone>+8615810110118</phone>
    <email>zhangqiu3660@icloud.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The capital health research and development of special</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hua MENG</last_name>
      <phone>+8613488882358</phone>
    </contact>
    <contact_backup>
      <last_name>Qiu-yue ZHANG</last_name>
      <phone>+8615810110118</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 31, 2013</study_first_submitted>
  <study_first_submitted_qc>December 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 25, 2014</study_first_posted>
  <last_update_submitted>December 21, 2014</last_update_submitted>
  <last_update_submitted_qc>December 21, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 25, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Friendship Hospital</investigator_affiliation>
    <investigator_full_name>Hua Meng</investigator_full_name>
    <investigator_title>Endoscopic Submucosal Dissection combine with Laparoscopic Regional Lymph node Dissection for early gastric cancer</investigator_title>
  </responsible_party>
  <keyword>Endoscopic Submucosal Dissection</keyword>
  <keyword>Laparoscopic Regional Lymph node Dissection</keyword>
  <keyword>early gastric cancer</keyword>
  <keyword>Disease-free survival</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

